𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NEUROPROTECTIVE EFFECTS OF A SELECTIVE N-METHYL-d-ASPARTATE NR2B RECEPTOR ANTAGONIST IN THE 6-HYDROXYDOPAMINE RAT MODEL OF PARKINSON'S DISEASE

✍ Scribed by KR Leaver; HN Allbutt; NJ Creber; M Kassiou; JM Henderson

Book ID
108940406
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
270 KB
Volume
35
Category
Article
ISSN
0305-1870

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of levodopa-induced dyskinesi
Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin
✍ Marc Morissette; Mehdi Dridi; Frédéric Calon; Abdallah Hadj Tahar; Leonard T. Me 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

## Abstract Enkephalin is reported to play an important role in the pathophysiology of levodopa (LD) ‐induced dyskinesias. The present study investigated the effect of chronic treatment with a selective NR1A/2B __N__‐methyl‐D‐aspartate (NMDA) receptor antagonist, CI‐1041, on the expression of prepr

N-0923, a selective dopamine D2 receptor
N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease
✍ Dr. J. D. Belluzzi; E. F. Domino; J. M. May; K. S. Bankiewicz; D. A. McAfee 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 800 KB

## Abstract Certain aminotetralins are known to be potent dopamine D~2~ receptor agonists. N‐0923, [‐]2‐(N‐propyl‐N‐2‐thienylethylamino)‐5‐hydroxytetralin HCl, recognizes the high and low affinity states of the D~2~ receptor in membranes from bovine caudate with a K~low~ of 79 nM. The selectivity r